What to Watch in U.S. Stocks Ahead of Earnings Season

David Keller discusses market volatility reminiscent of 2011, focusing on commodities and inflation concerns. He analyzes the S&P 500's technical resistance levels and compares its performance to global markets, highlighting the S&P's outperformance. Concerns are raised about the financial sector's underperformance, especially big cap banks, amid trade war fears. In contrast, the biotech sector shows promise with potential breakouts, offering opportunities for growth.

What potential outcomes are discussed regarding the S&P 500 as it approaches resistance levels?

What is the significance of the 2700 level mentioned in the context of market consolidation?

How does the performance of the S&P 500 compare to the rest of the world according to the discussion?

What are the key concerns regarding the financial sector as earnings season approaches?

What indicators suggest that biotech might perform well in the upcoming earnings season?